Impact of CYP2C19 genotype in ischaemic stroke patients treated with clopidogrel

被引：0
|
作者：
Doney, A. [1 ]
Palmer, C. [1 ]
Morant, S. [2 ]
Flynn, R. [2 ]
MacDonald, T. [2 ]
机构：
[1] Univ Dundee, Pharmacogen Ctr, Dundee, Scotland
[2] Univ Dundee, Med Monitoring Unit, Dundee, Scotland
来源：
INTERNATIONAL JOURNAL OF STROKE | 2015年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
043
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [1] CYP2C19 Genotype and Early Ischemic Lesion Recurrence in Stroke Patients Treated with Clopidogrel
    Jeong, Tae-Dong
    Kim, Seung Min
    Kim, Hyo Jin
    Lee, Woochang
    Kwon, Sun U.
    Min, Won-Ki
    Kang, Dong-Wha
    Chun, Sail
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (02): : 440 - 446
  • [2] The Impact of CYP2C19 Polymorphisms on Clinical Outcomes of the Patients Treated with Clopidogrel
    Lee, Y.
    Kim, M.
    Kim, H.
    Lee, E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 760 - 760
  • [3] Efficacy of clopidogrel for stroke depends on CYP2C19 genotype and risk profile
    Xu, Jie
    Wang, Anxin
    Wangqin, Runqi
    Mo, Jinglin
    Chen, Zimo
    Dai, Liye
    Meng, Xia
    Zhao, Xingquan
    Wang, Yilong
    Li, Hao
    Chen, Wei
    Xian, Ying
    Wang, Yongjun
    ANNALS OF NEUROLOGY, 2019, 86 (03) : 419 - 426
  • [4] CYP2C19 Genotype and Outcomes of Clopidogrel Treatment
    Geisler, Tobias
    Bigalke, Boris
    Schwab, Matthias
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05): : 481 - 481
  • [5] Cyp2c19 Polymorphisms Are Not Associated With the Longterm Clinical Outcomes in Stroke Patients Treated With Clopidogrel
    Tanaka, Tomotaka
    Yamagami, Hiroshi
    Ihara, Masafumi
    Hamasaki, Toshimitsu
    Miyata, Shigeki
    Miyata, Toshiyuki
    Yamamoto, Haruko
    Toyoda, Kazunori
    Nagatsuka, Kazuyuki
    STROKE, 2016, 47
  • [6] Effects of CYP2C19 Variants on Platelet Reactivity in Acute Stroke Patients Treated with Clopidogrel
    Lei, Qi
    Yang, Qian
    Wang, Qian
    Yang, Jiangcun
    Lv, Jianmeng
    Guo, Xiaomin
    Kang, Bei
    ANNALS OF NEUROLOGY, 2015, 78 : S28 - S28
  • [7] CYP2C19 genotyping and adjustments in clopidogrel therapy in stroke patients
    Keyany, A.
    Leenders, T.
    Maat, B.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (03) : 818 - 818
  • [8] Effect of CYP2C19*2 and *3 on clinical outcome in ischemic stroke patients treated with clopidogrel
    Wang, Yingting
    Cai, Huan
    Zhou, Guoqing
    Zhang, Zhizhong
    Liu, Xinfeng
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 369 : 216 - 219
  • [9] CYP2C19 Genotype-Guided Antiplatelet Therapy Among Asian Patients with Ischaemic Stroke
    Chia Siang Kow
    Abdullah Faiz Zaihan
    Syed Shahzad Hasan
    Clinical Drug Investigation, 2021, 41 : 115 - 116
  • [10] CYP2C19 Genotype-Guided Antiplatelet Therapy Among Asian Patients with Ischaemic Stroke
    Kow, Chia Siang
    Zaihan, Abdullah Faiz
    Hasan, Syed Shahzad
    CLINICAL DRUG INVESTIGATION, 2021, 41 (01) : 115 - 116
12345